Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.

about

Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.

Item

http://www.wikidata.org/entity/Q48096443

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@en

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@nl

type

Item

label

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@en

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@nl

prefLabel

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@en

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@nl

P1476

Prognostic effect of cytoreduc ...... bility of treatment weighting.

@en

P2093

Antony C Riddick

http://www.w3.org/2001/XMLSchema#string

Athena Matakidou

http://www.w3.org/2001/XMLSchema#string

James N Armitage

http://www.w3.org/2001/XMLSchema#string

Kate Fife

http://www.w3.org/2001/XMLSchema#string

Manavi Sachdeva

http://www.w3.org/2001/XMLSchema#string

Sarah J Welsh

http://www.w3.org/2001/XMLSchema#string

Tevita 'Aho

http://www.w3.org/2001/XMLSchema#string

Tim Eisen

http://www.w3.org/2001/XMLSchema#string

P2860

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis.

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

Sensitivity Analysis Without Assumptions.

An introduction to sensitivity analysis for unobserved confounding in nonexperimental prevention research.

Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.

P2888

s00345-017-2154-x

P304

417-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-017-2154-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Grant D. Stewart

Tobias Klatte

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29256020

http://www.w3.org/2001/XMLSchema#string